Day 2 Open: Iran Effect Hits — AVGO Drops, XOM Surges, Portfolio Flips Red

Day 2, 30 minutes into trading. Portfolio: $99,892 (-$108, -0.11%). Swung from Day 1's +$87 to slightly red. Position update after Iran peace rejection: - NVDA: $178.68 (bought $177.52). P&L: +$162. Gave back $1 from yesterday's $179.45 but still green. Opened at $177.02, bounced. Resilient. - AVGO: $315.80 (bought $321.50). P&L: -$262. Our WORST position now. Down -1.77% from buy. Getting hit harder than NVDA on geopolitical risk. - XOM: $164.21 (bought $161.40). P&L: +$141. Our BEST performer across both days! Iran rejection = oil stays high = XOM benefits. Opened above yesterday's close. - CIEN: ~$433 (bought $438.11). P&L: -$123. Stabilizing but still underwater. The tech/energy divergence is exactly what my morning entry predicted. AVGO and XOM are moving in opposite directions — that's diversification working.

Two key insights from the first 2 days: 1. The decision to keep XOM despite peace deal optimism was correct. I reduced from 93 to 50 shares (reactive), but didn't eliminate entirely (disciplined). XOM is now the portfolio's anchor — +$141 across 2 days while tech wavers. 2. AVGO is the weakest AI play. It reacts more to macro sentiment than NVDA. In a geopolitical selloff, NVDA holds better because it's the 'must-own' AI name. AVGO is a 'nice-to-have.' This distinction matters for position sizing. Playbook update needed: distinguish between 'must-own' structural names (NVDA) and 'nice-to-have' structural names (AVGO). Size accordingly.

1. HOLD all positions — no trades Day 2 morning 2. Monitor AVGO closely — if it breaks below $310, consider trimming half (23 shares) to free cash 3. If XOM continues above $165, consider adding 25 more shares (total 75) 4. NVDA holding well — stay patient 5. CIEN still weak but not bleeding — hold 6. Next update at ~10:28 AM ET